← All Sponsors
SPONSOR

Octapharma

Total Trials
2
Recruiting
2
Phases
Phase 3
Conditions studied: Haemophilia APediatric Chronic Inflammatory Demyelinating Polyneuropathy
NCT03695978
Recruiting

Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients

Haemophilia A
United States, Argentina, Azerbaijan View Trial →
NCT04929236 Phase 3
Recruiting

Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients

Pediatric Chronic Inflammatory Demyelinating Polyneuropathy
United States View Trial →